Cargando…

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?

Systemic lupus erythematosus (SLE) is a chronic, multifactorial autoimmune disease with complex pathogenesis characterized by the imbalance of pro-inflammatory and anti-inflammatory cytokines. Janus kinases (JAKs), intracellular non-receptor tyrosine kinases, are essential for signal pathways of man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Patricia, Cardoneanu, Anca, Burlui, Alexandra Maria, Macovei, Luana Andreea, Bratoiu, Ioana, Buliga-Finis, Oana Nicoleta, Rezus, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569651/ https://www.ncbi.nlm.nih.gov/pubmed/36233087 http://dx.doi.org/10.3390/ijms231911788

Ejemplares similares

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
por: Richter, Patricia, et al.
Publicado: (2023)

Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?
por: Cardoneanu, Anca, et al.
Publicado: (2022)

Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023)

Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment
por: Macovei, Luana Andreea, et al.
Publicado: (2022)

Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration
por: Cardoneanu, Anca, et al.
Publicado: (2022)

The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review
por: Bratoiu, Ioana, et al.
Publicado: (2022)

Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus
por: Richter, Patricia, et al.
Publicado: (2022)

Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background
por: Rezuș, Elena, et al.
Publicado: (2021)

Diet in Scleroderma: Is There a Need for Intervention?
por: Burlui, Alexandra Maria, et al.
Publicado: (2021)

From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside
por: Rezuş, Elena, et al.
Publicado: (2021)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2022)

Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2023)

Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021)

MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
por: Tanase, Daniela Maria, et al.
Publicado: (2022)

The Link Between Inflammaging and Degenerative Joint Diseases
por: Rezuș, Elena, et al.
Publicado: (2019)

Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report
por: Rezuș, Elena, et al.
Publicado: (2020)

A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study
por: Rezus, Elena, et al.
Publicado: (2020)

Inactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age
por: Rezuş, Elena, et al.
Publicado: (2020)

Adult-onset Still's disease and the role of dermatological manifestations: A case report and literature review
por: Vâță, Andrei, et al.
Publicado: (2021)

Predictors Associated with Adverse Pregnancy Outcomes in a Cohort of Women with Systematic Lupus Erythematosus from Romania—An Observational Study (Stage 2)
por: Vicoveanu, Petronela, et al.
Publicado: (2022)

Direct Oral Anticoagulants for Stroke and Systemic Embolism Prevention in Patients with Left Ventricular Thrombus
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
por: Rezus, Elena, et al.
Publicado: (2021)

Preparing for Pregnancy in Women with Systemic Lupus Erythematosus—A Multidisciplinary Approach
por: Saulescu, Ioana Cristina, et al.
Publicado: (2022)

A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus
por: Li, Yupeng, et al.
Publicado: (2019)

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
por: Kotyla, Przemysław, et al.
Publicado: (2022)

The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
por: Piga, Matteo, et al.
Publicado: (2021)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Predictors of major infections in systemic lupus erythematosus
por: Ruiz-Irastorza, Guillermo, et al.
Publicado: (2009)

Unmet medical needs in systemic lupus erythematosus
por: Lateef, Aisha, et al.
Publicado: (2012)

Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats
por: Rusu-Zota, Gabriela, et al.
Publicado: (2021)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets?
por: Sawaf, Matthieu, et al.
Publicado: (2016)

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
por: Hajji, Meriam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7tkak4255cpr4911mss5jsa3d8